.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Novartis
Colorcon
US Department of Justice
Federal Trade Commission
Chinese Patent Office
Johnson and Johnson
Queensland Health
Chubb
Covington

Generated: July 23, 2017

DrugPatentWatch Database Preview

VANCERIL Drug Profile

« Back to Dashboard

What is the patent landscape for Vanceril, and when can generic versions of Vanceril launch?

Vanceril is a drug marketed by Schering and is included in two NDAs.

The generic ingredient in VANCERIL is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.

Summary for Tradename: VANCERIL

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list32
Clinical Trials: see list1
Patent Applications: see list4,959
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VANCERIL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
VANCERIL
beclomethasone dipropionate
AEROSOL, METERED;INHALATION017573-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Schering
VANCERIL DOUBLE STRENGTH
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020486-001Dec 24, 1996DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VANCERIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
VANCERIL
beclomethasone dipropionate
AEROSOL, METERED;INHALATION017573-001Approved Prior to Jan 1, 19824,225,597► Subscribe
Schering
VANCERIL
beclomethasone dipropionate
AEROSOL, METERED;INHALATION017573-001Approved Prior to Jan 1, 19824,414,209► Subscribe
Schering
VANCERIL
beclomethasone dipropionate
AEROSOL, METERED;INHALATION017573-001Approved Prior to Jan 1, 19824,364,923► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Merck
Argus Health
Chinese Patent Office
Queensland Health
UBS
Accenture
Cipla
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot